TickerFactsScreenerDevelopers

Arbutus Biopharma Corp (ABUS) — Net Income

Annual figures by fiscal year, from SEC filings.

2011: -$10.08M2012: $29.61M2013: -$14.06M2014: -$38.84M2015: -$62.72M2016: -$384.16M2017: -$84.41M2018: -$57.06M2019: -$153.72M2020: -$63.74M2021: -$76.25M2022: -$69.46M2023: -$72.85M2024: -$69.92M2025: -$33.50M-$33.50M
2011Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$33.50M+52.1%
2024-$69.92M+4.0%
2023-$72.85M-4.9%
2022-$69.46M+8.9%
2021-$76.25M-19.6%
2020-$63.74M+58.5%
2019-$153.72M-169.4%
2018-$57.06M+32.4%
2017-$84.41M+78.0%
2016-$384.16M-512.5%
2015-$62.72M-61.5%
2014-$38.84M-176.2%
2013-$14.06M-147.5%
2012$29.61M+393.7%
2011-$10.08M—